| 000 | 01787 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516080323.0 | ||
| 264 | 0 | _c20120821 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1477-7819 | ||
| 024 | 7 |
_a10.1186/1477-7819-10-41 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeng, Chieh-Lin | |
| 245 | 0 | 0 |
_aSorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study. _h[electronic resource] |
| 260 |
_bWorld journal of surgical oncology _cFeb 2012 |
||
| 300 |
_a41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzenesulfonates _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Status Indicators |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aLiver Transplantation _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aStatistics as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aHwang, Wen-Li | |
| 700 | 1 | _aChen, Yi-Ju | |
| 700 | 1 | _aChang, Kuang-Hsi | |
| 700 | 1 | _aCheng, Shao-Bin | |
| 773 | 0 |
_tWorld journal of surgical oncology _gvol. 10 _gp. 41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1477-7819-10-41 _zAvailable from publisher's website |
| 999 |
_c21550345 _d21550345 |
||